Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Quince Therapeutics, Inc. (QNCX) had Weighted-Average Shares Outstanding (Basic) of 50.10M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-83.98M |
|
-- |
|
-- |
|
$58.07M |
|
$-58.07M |
|
$-22.70M |
|
$-80.77M |
|
$-80.77M |
|
$-83.98M |
|
$-83.98M |
|
$-83.98M |
|
$-83.98M |
|
$-58.07M |
|
$-58.94M |
|
|
Weighted-Average Shares Outstanding (Basic) |
50.10M |
50.10M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$22.90M |
|
$0.59M |
|
$70.63M |
|
$93.52M |
|
$43.23M |
|
-- |
|
$86.01M |
|
$129.24M |
|
$-35.71M |
|
$-103.53M |
|
$-35.71M |
|
55.73M |
|
| Cash Flow Statement Financials | |
$-41.42M |
|
$23.23M |
|
$17.91M |
|
$6.21M |
|
$5.81M |
|
$-0.40M |
|
$5.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-- |
|
-0.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
235.14% |
|
81.11% |
|
-89.80% |
|
235.14% |
|
$-0.64 |
|
$-0.83 |
|
$-0.83 |
|